The Relationship between VEGFA and TGFB1 Polymorphisms and Target Lesion Revascularization after Elective Percutaneous Coronary Intervention
Table 1
Baseline clinical and procedural characteristics.
Clinical characteristics ( patients)
Age (years)
63.4 ± 9.3
Female
194 (28.7)
Hypertension
467 (69.1)
Diabetes mellitus
181 (26.8)
Previous myocardial infarction
369 (54.6)
Atrial fibrillation
89 (13.1)
Previous PCI
277 (41)
Previous CABG
66 (9.8)
Creatinine (μmol/l)
84.3 ± 34.1
Procedural characteristics ( lesions)
Vessel treated
LM
15 (1.9)
LAD
220 (27.3)
Cx
257 (31.9)
RCA
300 (37.3)
SVG
13 (1.6)
Ostial lesion
19 (2.4)
Bifurcation lesion
75 (9.3)
Number of stents implanted per lesion
1.1 ± 0.34
Total stent length per lesion (mm)
19.5 ± 9.4
Minimal stent diameter (mm)
3.01 ± 0.54
Predilatation
412 (51.2)
Postdilatation
72 (8.9)
Continuous variables are presented as the mean ± standard deviation. Categorical variables are presented as number of patients/lesions (percentages). PCI: percutaneous coronary intervention; CABG: coronary artery bypass grafting; LM: left main; LAD: left anterior descending; Cx: circumflex branch; RCA: right coronary artery; SVG: saphenous vein graft.
